Two Sigma Securities’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-12,143
Closed -$1.7K 3858
2024
Q1
$1.7K Buy
+12,143
New +$2.39K ﹤0.01% 2862
2022
Q1
Sell
-23,463
Closed -$108K 2619
2021
Q4
$108K Buy
+23,463
New +$77.6K ﹤0.01% 1168

Other funds holding GRTX

Two Sigma Securities's GRTX Position: Q2 2024 in Review

Two Sigma Securities sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q2 2024, closing a stake of 12,143 shares — an estimated $1.7K sold.

Two Sigma Securities first reported a position in GRTX in Q4 2021 and held it in 2 quarters. The position peaked at $108K in Q4 2021. 1 fund tracked by Wall St. Rank holds GRTX as of Q2 2024.

  • Two Sigma Securities reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Two Sigma Securities sold 12,143 Galera Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $1.7K.
  • Two Sigma Securities first reported a position in Galera Therapeutics, Inc. Common Stock in Q4 2021 and held it in 2 quarters.
  • Two Sigma Securities's Galera Therapeutics, Inc. Common Stock position peaked at $108K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q2 2024.

Based on Two Sigma Securities's 13F filing for Q2 2024, filed 14 Aug 2024.